Sign up for the QMED & MD+DI Daily newsletter.
Former J&J Execs Say Firm Ignored Concerns About Contraceptive Safety
Johnson & Johnson is facing more than 2400 lawsuits over its Ortho Evra birth-control patch. And now, reports the Star-Ledger of Newark, NJ, those plaintiffs' cases may receive a boost from two former J&J executives. They say they raised concerns about the patch's safety but were ignored. The identity of one, Joel Lippman, a former medical officer, was made known last year when he filed a whistleblower lawsuit.
September 19, 2007
1 Min Read
But court documents now reveal a second whistleblower, a former vice president who resigned rather than sign off on a "benefit and risk safety evaluation" he disagreed with. The patch has been linked to blood clots -- possibly fromÂ great estrogen exposure --Â and the plantiffs allege that J&J knew it had greater risks than birth-control pills (which have as much asÂ 60% less estrogen than the patch), but marketed it agressively, underplaying the dangers.Postmarket studies are ongoing, and results so far have been contradictory. They could ultimately decide the fate of the lawsuits. In the meantime, J&J has a very messy situation on its hands.
You May Also Like
Empatica Launch Next-Gen FDA-Cleared Epilepsy WatchMar 1, 2024|2 Min Read
Safeguard Medical Devices: A Complete Approach to Device Lifecycle SecurityApr 4, 2024|13:00 EDT
Boston Sci Nabs FDA Approval for Agent DCBMar 1, 2024|2 Min Read
Masimo Takes Apple's Hail Mary Pass in StrideFeb 29, 2024|3 Min Read